Halozyme Therapeutics (NASDAQ:HALO) Shares Up 8.2%

Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) shot up 8.2% on Tuesday . The stock traded as high as $38.27 and last traded at $38.14. 161,983 shares traded hands during trading, a decline of 86% from the average session volume of 1,193,845 shares. The stock had previously closed at $35.26. Wall Street […]

Leave a Reply

Your email address will not be published.

Previous post Rocky Mountain Chocolate Factory, Inc. (NASDAQ:RMCF) Major Shareholder Buys $36,410.22 in Stock
Next post Stride (NYSE:LRN) Sets New 52-Week High at $56.80